Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adhere+ is a Washington, D.C.-based digital health company that provides a SaaS-based remote therapeutic monitoring (RTM) platform designed to improve patient adherence and clinical outcomes in chronic care. The platform, often marketed under the names PainScript and HealthScript, utilizes customizable daily check-ins to collect electronic patient-reported outcomes (ePROs), offering healthcare providers real-time insights into patient compliance and symptom progression. Focused primarily on chronic pain management, opioid use disorder, and obesity, Adhere+ helps clinicians titrate treatment protocols and reduce administrative burdens while aligning with reimbursable CPT codes. The technology is clinically validated through multiple peer-reviewed trials and supports various specialties including neurology and behavioral health. In March 2025, the company was acquired by Optimus Healthcare for $4.5 million to enhance its integrated chronic care management offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adhere+.